Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Amniotic Membrane Market Growth From $2.08 Billion In 2026 To $3.15 Billion By 2030 At A CAGR Of 10.9%

The market for amniotic membrane has experienced significant expansion recently. Projections indicate a rise from $1.88 billion in 2025 to $2.09 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.8%. This past growth was fueled by several key factors, including the burgeoning field of regenerative medicine research, escalating demands for surgical wound management solutions, increased utilization within ophthalmology, the presence of advanced tissue preservation technologies, and the growing trend of biological treatments administered in hospital settings.

The amniotic membrane market is projected for substantial expansion, reaching an estimated value of $3.15 billion by 2030 with a projected compound annual growth rate of 10.9%. This anticipated surge is fueled by several key factors, including a heightened need for sophisticated wound healing treatments, a greater incorporation into less invasive surgical techniques, the proliferation of ambulatory surgical centers, a stronger emphasis on therapeutic approaches utilizing biological agents, and clearer regulatory frameworks for products derived from tissues. Over the forecast horizon, significant trends expected to shape the market include a growing utilization of amniotic membranes in regenerative medicine, increased application in eye surgeries, broader use in managing wounds, a rising preference for cryopreserved forms, and an intensified commitment to ensuring the safety of biological products.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8830&type=smp

#Amniotic Membrane Market Growth Factors: Which Forces Are Supporting Market Expansion?

A surge in organ and tissue transplantation procedures is anticipated to fuel the expansion of the amniotic membrane market. Transplantation, a process where tissues or organs are surgically moved from a donor to a recipient, frequently incorporates amniotic membranes to aid in surgical interventions and reconstructive efforts, thereby fostering tissue regeneration and patient recovery. This heightened transplantation activity is a direct result of increased public awareness regarding organ donation, advancements in surgical methodologies, and more sophisticated donor-recipient matching algorithms. Amniotic membrane allografts contribute to the healing process post-transplantation by offering a biologically active extracellular matrix along with regulatory proteins that encourage tissue rebuilding. Illustrating this trend, the Organ Procurement and Transplantation Network (OPTN) reported that in 2023, the United States performed a total of 46,632 organ transplants, an 8.7 percent increase from the previous year, with a further 3.6 percent rise to 41,119 deceased-donor transplants observed in the first part of 2024, demonstrating sustained growth in transplant procedures. Consequently, the escalating volume of transplant activities is a key driver for the amniotic membrane market.

The escalating incidence of long-term illnesses is poised to stimulate further growth within the amniotic membrane market. Chronic diseases are defined as conditions that persist for a minimum of three months and have the potential to worsen over time. The amniotic membrane, owing to its inherent anti-inflammatory and regenerative characteristics, proves exceptionally useful in managing these persistent health issues, mitigating associated complications, and addressing tissue deterioration. The broad applicability of the amniotic membrane across different medical fields addresses the pressing need for efficient therapeutic interventions required for chronic conditions. For example, projections from the World Health Organization in February 2024 indicated that by 2050, approximately 35 million new cancer diagnoses are expected, representing a significant 77% jump from the estimated 20 million cases recorded in 2022. Accordingly, the growing prevalence of chronic diseases is a significant factor contributing to the expansion of the amniotic membrane market.

Amniotic Membrane Market Segmentation And Category Breakdown

The amniotic membrane market covered in this report is segmented –

1) By Product: Cryopreserved Amniotic Membrane, Lyophilization Amniotic Membrane

2) By Application: Surgical Wounds, Ophthalmology, Other Applications

3) By End-Use: Hospitals, Ambulatory Surgical Centers (ASCs), Other End-Users

Subsegments:

1) By Cryopreserved Amniotic Membrane: Dehydrated Cryopreserved Amniotic Membrane, Fresh Cryopreserved Amniotic Membrane

2) By Lyophilization Amniotic Membrane: Sterilized Lyophilized Amniotic Membrane, Non-Sterilized Lyophilized Amniotic Membrane

Amniotic Membrane Market Industry Trends: What Changes Are Reshaping Demand?

The foremost entities within the amniotic membrane sector are dedicating their efforts to the creation of sophisticated allografts, aiming to enhance patient well-being and achieve superior clinical results. Amniotic membrane allografts, which are sourced from the innermost placental layer, serve a crucial role in addressing ocular and surgical tissue damage by furnishing a natural extracellular matrix along with growth factors that foster accelerated healing. As an illustration, in December 2024, BioTissue, a prominent American biotechnology firm, introduced CAM360 AmnioGraft (CAM360 AG), a shelf-stable, cryopreserved amniotic membrane product that notably lacks a ring, designed for the management of dry eye conditions ranging from mild to moderate, and for halting the progression of early-stage neurotrophic keratitis. This innovative product bestows upon eye care practitioners a range of adaptable application methods, encompassing placement beneath a bandage contact lens or in conjunction with a collagen shield, and importantly, facilitates prompt symptom alleviation typically within a 48-hour timeframe. Furthermore, CAM360 AG not only broadens the spectrum of therapeutic possibilities but also streamlines inventory oversight for healthcare facilities, thus underscoring how advancements such as CAM360 AG are instrumental in propelling the expansion of the amniotic membrane market.

Amniotic Membrane Market Competitive Analysis Of Major Industry Participants

Major companies operating in the amniotic membrane market are MiMedx Group Inc, Organogenesis Holdings Inc, Amnio Technology LLC, Applied Biologics LLC, Human Regenerative Technologies LLC, Skye Biologics Inc, Amniox Medical Inc, Bio-Tissue Inc, TissueTech Inc, Osiris Therapeutics Inc, VIVEX Biologics Inc, Merakris Therapeutics Inc, Celularity Inc, BioLab Sciences, LifeCell International Pvt. Ltd., FzioMed Inc, Corza Ophthalmology, Integra LifeSciences Co, Smith & Nephew, RTI Surgical

Access The Complete Amniotic Membrane Market Report:

https://www.thebusinessresearchcompany.com/report/amniotic-membrane-global-market-report

Amniotic Membrane Market Regional Analysis: Which Region Leads By Revenue?

North Americawas the largest region in the amniotic membrane market share in 2025.Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the amniotic membrane market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model